Urine samples were collected from 51 participants in a study investigating pesticide exposure among farm families in Iowa. Aliquots from the samples were sent to two different labs and analyzed for metabolites of atrazine (atrazine mercapturate), metolachlor (metolachlor mercapturate) and chlorpyrifos (TCP) by two different analytical methods: immunoassay and high performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS). HPLC-MS/MS methods tend to be highly specific, but are costly and time consuming. Immunoassay methods are cheaper and faster, but can be less sensitive due to cross reactivity and matrix effects. Three statistical methods were employed to compare the two analytical methods. Each statistical method differed in how the samples that had results below the limit of detection (LOD) were treated. The first two methods involved an imputation procedure and the third method used maximum likelihood estimation (MLE). A fourth statistical method that modeled each lab separately using MLE was used for comparison. The immunoassay and HPLC-MS/MS methods were moderately correlated (correlation 0.40-0.49), but the immunoassay methods consistently had significantly higher geometric mean (GM) estimates for each pesticide metabolite. The GM estimates for atrazine mercapturate, metolachlor mercapturate, and TCP by immunoassay ranged from 0.16-0.98 mg l À1 , 0.24-0.45 mg l À1 and 14-14 mg l À1 , respectively and by HPLC-MS/ MS ranged from 0.0015-0.0039 mg l À1 , 0.12-0.16 mg l
Introduction
Atrazine, metolachlor, and chlorpyrifos are commonly used pesticides in US agricultural crop production, ranking 2, 10, and 15 respectively in terms of usage and accounting for a total of approximately 97-112 million pounds of pesticides used in 2001 (EPA, 2004 . Metabolites of these pesticides have been analyzed in the urine of farmers exposed to them using various chromatography, mass spectrometry (MS), and immunoassay analytical methods (Perry et al., 2000; Arbuckle et al., 2005; Chuang et al., 2005; Curwin et al., 2005) .
Biological monitoring is often employed to assess exposure to pesticides, but a reliable, accurate, sensitive, and convenient method for analyzing pesticides in urine is necessary. Mass spectrometry (MS)-based methods such as gas chromatography (GC) -MS and high performance liquid chromatography (HPLC)-MS have been classically used but these procedures are costly, time consuming, labor intensive, and require expensive equipment and highly trained personnel. The advantage of these methods is that they are usually highly specific (Biagini et al., 2004) . HPLC tandem mass spectrometry (HPLC-MS/MS) methods have been developed recently for pesticides that have lower limits of detection, are less time consuming, and have greater throughput (Olsson et al., 2004) . Immunoassay methods such as enzyme-linked immunosorbent assays (ELISA) or fluorescent covalent microbead immunosorbent assays (FCMIA) provide an alternative to the classical analytical methods for pesticide analysis. These immunoassay methods are generally inexpensive, relatively fast, have high throughputs, and can be performed on relatively inexpensive equipment (Biagini et al., 2004) . Immunoassay methods are also adaptable to direct reading field assays, allowing for real-time analysis of samples. Immunoassay methods, however, may not be specific or may suffer from matrix effects in urine limiting their sensitivity by a factor of 10-to 100-fold (Biagini et al., 2004) , and therefore may not be the best choice for a confirmatory analysis.
Comparisons of MS-based and immunoassay methods have been made for various compounds in various matrices (Amistadi et al., 1997; Perry et al., 2000; Shimoi et al., 2002; Chuang et al., 2005) . However, to date, a comparison of HPLC-MS/MS and immunoassay methods for measuring metabolites of atrazine, metolachlor, and chlorpyrifos in urine from farmers has not been done. This paper presents a comparison of immunoassay and HPLC-MS/MS analytical methods for measuring the metabolites of these three pesticides in the urine of farmers.
Methods
In the spring and summer of 2001, 50 families (25 farm and 25 non-farm) in Iowa were enrolled in a study investigating agricultural pesticide contamination inside homes and family pesticide exposure. Participant recruitment has been described earlier (Curwin et al., 2002) . To be eligible for the study, the non-farm family had to live in a home on land that was not used for farming, and not be working in agriculture or commercial pesticide application. The farm family had to be using at least one of seven target pesticides: atrazine, acetochlor, metolachlor, alachlor, chlorpyrifos, glyphosate, or 2,4-D. All of these pesticides are corn or soybean herbicides, with the exception of chlorpyrifos, which is an insecticide used on corn and soybean and other crops.
Sample Collection
During May, June, July, and August 2001, each family was visited on two occasions. The first visit to a farm family was shortly after an application event (within 1-5 days), with visits to non-farm families scheduled to coincide with a farm visit. The second visit was approximately 4 weeks later (average 4 weeks, range 3-5 weeks). Two spot urine samples were collected on each visit from the participants, one in the evening of the day of the visit, and one the following morning. The urine samples were collected in 500 ml nalgene bottles and the participants were asked to store the urine in their refrigerator, or in a cooler with ice packs that was provided. The samples were collected by study investigators the day after the visit and 25-ml aliquots were removed, stored on dry ice and shipped to the laboratory. The total volume of each urine void was recorded.
A total of 178 urine voids from a subset of 51 farm and non-farm family members (89 samples from 24 farm fathers, two samples from one farm mother, 80 samples from 23 nonfarm fathers, and seven samples from three non-farm mothers) were of sufficient volume to be split and analyzed by two different laboratories. The first laboratory (Lab 1, National Center for Environmental Health) analyzed the split aliquots for urinary metabolites of atrazine, metolachlor, and chlorpyrifos using HPLC-MS/MS; the second laboratory (Lab 2, National Institute for Occupational Safety and Health) analyzed the split aliquots for urinary metabolites of atrazine and chlorpyrifos using ELISA methods and metolachlor using FCMIA methods. The limits of detection (LOD) varied by both analyte and method (Table 1) ; Lab 1 had lower LODs compared with Lab 2, particularly for atrazine mercapturate.
Sample Analysis
A 25-ml aliquot from each urine sample was sent to Lab 1 for analysis by HPLC-MS/MS and to Lab 2 for the immunoassay analysis. The metabolites of three pesticides Fatrazine (atrazine mercapturate), metolachlor (metolachlor mercapturate), and chlorpyrifos (3,5,6-trichloropyridinol (TCP)) were measured. The average LOD for each method and pesticide metabolite are presented in Table 1 . In some cases, the labs reported values below the average LOD and these values were used depending on the statistical analysis used. Values reported at or below the average LOD have more uncertainty associated with them than values greater than the LOD, however, this uncertainty is considered less than using an imputed value for samples below the LOD.
The samples analyzed by HPLC-MS/MS used recently published methods (Olsson et al., 2004; Norrgran et al., 2006) . Briefly, a 2-ml aliquot of urine was spiked with isotopically labeled standards, and then diluted with 1.5 ml 0.2 M acetate buffer to which 800 activity units of b-glucuronidase/sulfatase had been added. The solution was allowed to incubate at 371C overnight to liberate glucuronide-and sulfate-bound conjugates. The hydrolysate was applied to an OASIS s HLB solid phase extraction cartridge (Waters Corporation, Milford, MA, USA). The SPE cartridge was washed with 2 ml 5% methanol in 1% acetic acid and eluted with 1.5 ml methanol. The methanol was diluted with 2 ml acetonitrile then evaporated to dryness. The residue was reconstituted in 50 ml acetonitrile. Pesticide metabolites were measured in the sample extract using HPLC-MS/MS with atmospheric pressure chemical ionization. A multiple reaction monitoring experiment was used to isolate specific precursor and product ion pairs for each analyte measured. Calibration standards, quality control materials and blank samples were prepared and analyzed concurrently with unknown samples. The concentrations of the three pesticide metabolites were calculated using isotope dilution quantification. The LOD was calculated as three times the SD of noise at zero concentration.
The samples analyzed by immunoassay used ELISA for atrazine mercapturate and TCP, and FCMIA for metolachlor mercapturate. The LODs for the immunoassay methods were defined as 90% bound antibody divided by unbound antibody (90% B/B0). Immunoassay for Atrazine (A00071) RaPID Assay s ELISA kit (Strategic Diagnostics, Newtown, PA, USA) was used to determine the metabolite atrazine mercapturate according to the manufacturer's instructions with the following exception: calibration standards (0.0, 0.1, 0.5, 1.0, 2.0, and 5.0 p.p.b.) were prepared by fortifying pooled urine from anonymous volunteers diluted 1:10 with UriSub (A synthetic buffered solution physically equivalent to normal urine, CST Technologies Inc., Great Neck, NY, USA) with synthesized atrazine mercapturate. All participant urine samples were diluted 1:10 with UriSub.
A previously published immunoassay for TCP was used to determine the urinary metabolite of chlorpyrifos (MacKenzie et al., 2000) . The immunoassay kit for TCP (A00208) RaPID Assay ELISA (Strategic Diagnostics, Newtown, PA, USA) was used according to the manufacturer's instructions with the following exception: calibration standards (0.0, 0.0156, 0.3125, 0.625, 1.25, 2.5, 5.0, and 10.0 p.p.b.) were prepared by fortifying UriSub with TCP. All participant urine samples were diluted 1:10 with UriSub. The method described by Mackenzie et al. (2000) uses a minimum 1:50 urinary dilution to avoid urine matrix effects. However, a 1:10 dilution was considered appropriate to bring the samples into the detection range for this method given the concentration range of TCP in urine found in these samples. In addition, each sample was treated with 20 ml of b-glucuronidase (Roche Diagnostics, part no. 1-585-665, Mannheim, Germany) for 30 min at room temperature prior to analysis to cleave TCP from its glucuronide conjugate form.
Metolachlor mercapturate was measured in urine using a recently developed FCMIA (Biagini et al., 2004) . A pesticide-protein conjugate for the pesticide was coupled to an addressable set of microbeads. The conjugate-coupled microbeads were then used in a competitive assay for the pesticide metabolite. The pesticide metabolite in solution competed with the bead-bound conjugate for fluorescently labeled anti-pesticide antibodies; thus increasing concentrations of a given pesticide in urine resulted in decreasing fluorescence signals from the microbead for that pesticide. Calibration standards (0.0, 0.1, 0.3, 1.0, 3.0, 10.0, 30.0, 100, and 300 p.p.b.) were prepared. These standards were prepared from pooled urine diluted 1:10 in a mixture of assay buffer (Abraxis LLC, Hatboro, PA, USA) and UriSub(1:3) were fortified with metolachlor mercapturate.
Statistical Methods
All statistical analyses were performed using SAS 9 Software s (SAS Institute Inc., Cary, NC, USA). Percent agreement and Cohen's kappa, which measures agreement expected beyond chance, were initially used to compare the two analytical methods categorically (i.e., non-detect, detect). Agreement for detection above the LOD was not straightforward as the two methods have different LODs, therefore, kappa was computed using four categories (non-detect, valueoLOD 1 , LOD 1 rvalueoLOD 2 , and valueZLOD 2 ), where LOD i is the LOD for lab i, i ¼ 1, 2 (non-detect refers to samples where no value was reported by the lab; valueoLOD i refers to samples where a value was reported by the lab, but this value was less than the method LOD).
A quantitative comparison of the two methods needed to consider both the distribution of the urinary concentrations and the censoring at the LOD. Urinary concentrations were not normally distributed; rather, distributions were strongly skewed to the right. The distributions of TCP were approximately lognormal based on the ShapiroFWilk's test for both Lab 1 and Lab 2, but statistically significant departures from log-normality were observed for atrazine mercapturate (Lab 2) and metolachlor mercapturate (Lab 1 and Lab 2). As the distributions were closer to log-normal than normal, a logarithmic transformation was applied to the data. Three methods for dealing with the censored values (values below the LOD) were compared. First, as one or both of the labs provided estimated values for some or all of the censored values, the first method used these values, when available, and replaced non-detects with the minimum (positive) detected value; when no values were provided below the LOD, non-detects were replaced with one-half the LOD. The second method replaced all values below the LOD with one-half the LOD (Hornung and Reed, 1990) , regardless of whether a value below the LOD was reported by the lab. Finally, a third method considered all values below the LOD as censored at the LOD and used maximum likelihood estimation (MLE) methods to estimate the model parameters (Thie´baut and Jacqmin-Gadda, 2004) . The MIXED procedure in SAS was used to estimate model parameters using methods 1 and 2 and the NLMIXED procedure in SAS was used to estimate model parameters under method 3. All models specified an unstructured covariance matrix (i.e., covariance parameter estimates included separate variances for Lab 1 and Lab 2 and a covariance between Lab 1 and Lab 2). A single fixed effect for lab allowed for a comparison of the means for Lab 1 and Lab 2. Finally, for comparison purposes, a fourth method used the LIFEREG procedure in SAS to estimate geometric means (GMs) and geometric standard deviations (GSDs) separately for each lab using MLE; in this analysis, values below the LOD were censored at the LOD. Table 1 contains the percentage of samples below the LOD and selected percentiles by analyte and lab (method). For atrazine mercapturate, 131 (74%) urine samples were below the LOD and reported as non-detect based on the HPLC-MS/MS method (LOD ¼ 0.026 mg l À1 ) whereas 124 (70%) urine samples were below the LOD based on the ELISA method (LOD ¼ 1.16 mg l
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). Lab 2, however, reported estimated atrazine mercapturate levels below the LOD for 83 samples (range, 0.00076-1.156 mg l À1 ). Figure 1 displays urinary concentrations of atrazine mercapturate based on the HPLC-MS/MS method versus urinary concentrations of atrazine mercapturate based on the ELISA method. In this figure, values below the method-specific LODs are indicated as censored at the LOD. Urinary concentrations based on the ELISA method were generally higher than urinary concentrations based on the HPLC-MS/ MS method. For TCP, 40 (22%) urine samples were below the LOD and reported as a non-detect based on the HPLC-MS/MS method (LOD ¼ 0.5 mg l
) whereas only five (3%) urine samples were below the LOD based on the ELISA method (LOD ¼ 3.32 mg l À1 ). Lab 2, however, reported the estimated TCP levels for these five samples (range, 1.82-3.17 mg l
). Urinary concentrations of TCP based on the ELISA method were also generally higher than urinary concentrations based on the HPLC-MS/MS method (Figure 2) . When four categories were considered (non-detect, valueoLOD 1 , LOD 1 rvalueoLOD 2 , and valueZLOD 2 ), percentage agreement was 40%, 61%, and 15% percent for atrazine mercapturate, TCP, and metolachlor mercapturate, respectively. Agreement beyond chance, however, ranged from poor to none with Cohen's kappa statistics of 0.17, 0.03, and À0.01 for atrazine mercapturate, TCP, and metolachlor mercapturate, respectively.
Covariance parameter estimates based on the first three statistical methods are provided in Table 2 , along with estimated GMs and GSDs for the two labs based on the four statistical methods. Statistical methods 1 and 2 gave identical GM and GSD estimates for Lab 1 (GM 1 , GSD 1 ) for atrazine mercapturate and TCP as Lab 1 reported values below the LOD as ''non-detect'' rather than the estimated values for these analytes. Statistical methods 1-4 gave similar estimates for Lab 2 (GM 2 , GSD 2 ) for TCP, which was expected as 97% of the Lab 2 values for TCP were above the LOD; the four methods also gave similar estimates for GM 1 (GSD 1 ) for TCP where 78% of the Lab 1 values were above the LOD. For metolachlor mercapturate, 62% of Lab 1 and 56% of Lab 2 values were above the lab-specific LODs; compared with statistical method 3, statistical method 1 (which used reported values below the LOD) underestimated the GMs but overestimated the GSDs and statistical method 2 (which substituted one-half the LOD for censored observations) overestimated the GMs but underestimated the GSDs. Statistical methods 3 and 4 gave similar estimates of the GM and GSD. Atrazine mercapturate had the highest rates of censoring with only 26% of Lab 1 and 30% of Lab 2 values above the lab-specific LODs. For Lab 2, compared to statistical method 3, statistical method 1 underestimated the atrazine GM but overestimated the GSD and statistical method 2 overestimated the GM but underestimated the GSD. Statistical method 3 atrazine estimates for Lab 1 may be unstable, however, as 74% of the Lab 1 values were censored at the LOD. The instability is evidenced in the widely varying estimates for the Lab 1 GM and GSD provided by the different statistical methods.
The correlation between the labs measures the strength of the linear relationship between the (log transformed) urinary concentrations (Table 2 ). Compared to method 3, method 2 overestimated the correlation between the labs for all three of the analytes; method 1 correlations were somewhat inconsistent, sometimes higher and sometimes lower than the method 3 correlation. Method 3 correlation coefficients of 0.40, 0.47, and 0.49 for atrazine mercapturate, TCP, and metolachlor mercapturate, respectively, indicate that the urinary concentrations for the two labs were moderately correlated. Regardless of the statistical method employed, the GM for Lab 2 was statistically significantly higher than the GM for Lab 1 for all three of the analytes (Table 2 ). The Lab 2 GMs were approximately 40-300, 5, and 3 times higher than the Lab 1 GMs for atrazine mercapturate, TCP, and metolachlor mercapturate, respectively (Table 2) . A comparison of the 75th and 90th percentiles for atrazine mercapturate, however, indicated that the differences were not as great at higher concentrations with Lab 2 75th and 90th percentiles approximately 12 and 3 times higher than the Lab 1 percentiles (Table 1) .
Discussion
The GM urinary pesticide metabolite levels were consistently and significantly higher when urine samples were analyzed by the immunoassay methods compared with the HPLC-MS/ MS analysis. However, the two analytical methods were moderately correlated, suggesting an upward bias of the results from the immunoassay methods. Similarly, in a study comparing HPLC coupled to an electrochemical detector (ECD) and ELISA methods for the determination of urinary 8-hydroxy-2 0 -deoxyguanosine, a potential marker of oxidative DNA damage, the ELISA sample concentrations were 2-4 times higher than the HPLC-ECD concentrations with a correlation of R ¼ 0.46 (Shimoi et al., 2002) . In a comparison between HPLC and an immunoassay for urinary alachlor metabolites, the immunoassay estimates were approximately five times higher (Po0.0001) (Biagini et al., 1995) . However, good correlations were observed when comparing ELISA methods with GC methods for atrazine in water (R ¼ 0.95) and atrazine in soil (R ¼ 0.77) with ELISA sample concentrations only slightly greater than the GC concentrations (Amistadi et al., 1997) . Conversely, in a comparison of ELISA and GC for 2,4-dichlorophenoxyacetic acid (2,4-D) in urine, the mean concentrations by the ELISA method were slightly less than the GC methods, but again a good correlation was achieved (R ¼ 0.94) (Chuang et al., 2005) .
It is unclear why the immunoassay methods in this study had consistently higher urinary pesticide metabolite estimates than the HPLC-MS/MS method. A possible explanation for the greater estimates with the immunoassay methods is cross reactivity with other metabolites and urine matrix effects. This in some cases may limit the sensitivity of immunoassay methods by 10-to 100-fold (Biagini et al., 2004) . However, in an analysis of the ELISA method used in this study for TCP, the ELISA method had only slightly higher sample concentrations than a GC method, with good correlation between the two methods (R ¼ 0.98) (MacKenzie et al., 2000) . MacKenzie et al. (2000) used higher concentrations in their study than those found here. Perhaps at low concentrations, cross reactivity and matrix effects are more evident resulting in an upward bias only in the low concentration range. Given the low concentrations, a 1:10 urine dilution was used in the TCP ELISA analysis to bring the sample concentrations into the detection range of the method, whereas the method described by Mackenzie et al. (2000) uses a minimum 1:50 dilution to avoid urine matrix effects. The use of a smaller dilution ratio for the urine samples may have resulted in urine matrix effects that might account for some of the discrepancy seen between the two TCP analytical methods. The HPLC-MS/MS method also appears to be more specific at lower concentrations. The HPLCMS/MS LOD was substantially lower for TCP than that of other methods, whereas the between-day variability for the HPLC-MS/MS method ranged from 8% to 10% and the within-day variability ranged from 5% to 9% (Olsson et al., 2004) . The immunoassay LODs were approximately 2, 7, and 45 times higher than the HPLC-MS/MS LODs for metolachlor mercapturate, TCP, and atrazine mercapturate, respectively.
The implication of the disparity between the two methods, particularly if there is an upward bias with immunoassay methods, is that dose calculations using the immunoassay method would be biased upward resulting in a greater risk estimate associated with a given exposure. However, in a previous paper, a downward correction for this potential bias Method 1: when available, values below the LOD were used and non-detects were replaced with the minimum reported concentration, otherwise non-detects were replaced with one-half the LOD; method 2: all values below the LOD were replaced with one-half the LOD; and methods 3 and 4: all values below the LOD were censored at the LOD. Methods 1 and 2 used the MIXED procedure in SAS; method 3 used the NLMIXED procedure in SAS; and method 4 used the LIFEREG procedure in SAS (separate models for each lab). Methods 1-3 considered an unstructured covariance matrix, but treated each urine void as independent. was shown not to have a significant impact on risk estimates at the low concentrations observed (Curwin et al., 2007) .
Three statistical methods were used to deal with the censored data, with a fourth method that modeled each lab separately used for comparison. If we assume the comparison method (which used MLE methods on each lab separately) provides the most accurate GM and GSD estimates, then it appears that method three (which used MLE methods to model data from both labs simultaneously) is the best method for modeling the highly censored data from the two labs. In the case of atrazine, where 30% or less of the data was above the LODs, method three provides GMs closest to method 4. Methods 1 and 2 gave substantially different GMs compared with methods 3 and 4. This was not unexpected given that methods 1 and 2 involved an imputation procedure that, although simple to implement, has been shown to produce biased estimates when the majority of the samples are less than the LOD; the third method used MLE methods that have been shown to produce estimates that are less biased (Lubin et al., 2004; Hammel et al., 2006) . For TCP and metolachlor mercapturate, where greater than 50% of the samples were above the LOD, the estimated GMs are much closer. The GMs are practically the same for TCP, where better than 78% of the samples were above the LOD, but as the percentage of samples above the LOD decreases the estimated GMs start to vary more.
Another option for conducting the comparison of the HPLC-MS/MS with the immunoassay analytical methods would be to exclude all the data below the LOD. However, this option was considered impractical given the large differences in LODs between the two analytical methods. The difference in LODs and percentages of samples above the LOD for each analytical method would have surely biased the results.
The analyses described in this paper suffer from several limitations. First, the statistical methods employed assume that the underlying distribution of the urinary metabolites was log-normal, an assumption that may not be appropriate for atrazine and metolachlor. Second, up to two urine voids were collected from each individual on two occasions separated by approximately 4 weeks. Replicate urine voids from the same individual are not necessarily independent; however, the statistical methods employed assume the urine voids to be independent. Methods are not yet available for dealing with both censoring and repeated measures when the random effects are nested, as they are here, with two samples per visit and two visits per person. Finally, and perhaps most importantly, as each urine void was split into two aliquots, the first analyzed by Lab 1 using HPLC-MS/MS and the second analyzed by Lab 2 using ELISA/FCMIA techniques, the effects of method and lab are possibly confounded.
The dataset used to compare the two analytical methods was less than ideal for this purpose. The urinary concentration data were derived from a field study designed to characterize the exposure to farm families. Field data of this nature tend to be skewed to the right, with more samples in the low concentration range compared to the high concentration range. A more ideal dataset would include data with concentrations more evenly distributed over the range where the test would be expected to perform well and include replicates across the range of the data.
Conclusion
The immunoassay analytical methods for the analysis of atrazine mercapturate, metolachlor mercapturate, and TCP in urine gave significantly higher geometric mean estimates than the HPLC-MS/MS analytical method, however the methods were moderately correlated. Immunoassays tend to be cheaper and faster than HPLC-MS/MS, however, they may result in an upward bias of urinary pesticide metabolite levels. For definitive data HPLC-MS/MS may be the more appropriate method, however, the choice of method will depend on the exposures being considered. The statistical analysis of the data was somewhat complicated due to the fact that the LODs of the two methods differed sharply and due to high censoring of the data. Maximum likelihood estimation was useful for dealing with the censored data when conducting this type of comparison.
